Middlesex Pharmaceutical Group – Page 33 – Middlesex Pharmaceutical Group

- 17TH MARCH 2025
- 0 COMMENTS
National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials
National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials National Patient Safety Alert Reference Number: NatPSA/2025/001/DHSC Date issued: 17 March 2025 Explanation of identified safety issue Promixin® (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) are being discontinued from early May 2025, with stocks anticipated
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 14TH MARCH 2025
- 0 COMMENTS
Briefing 008/25: Briefing for general practice teams – the Community Pharmacy Respiratory Syncytial Virus (RSV) and Pertussis Vaccination Service
This Community Pharmacy England Briefing provides information for general practice teams on the Community Pharmacy RSV and Pertussis Vaccination Service, which has been commissioned from selected pharmacies by NHS England. Briefing 008.25 Briefing for general practice teams on NHS RSV and Pertussis Vaccination Service The post Briefing 008/25: Briefing for general practice teams – the
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England Briefings
- 14TH MARCH 2025
- 0 COMMENTS
Briefing 007/25: Briefing for pharmacy teams – the RSV and Pertussis Vaccination Service
This Community Pharmacy England Briefing provides information for pharmacy teams on the Respiratory Syncytial Virus (RSV) vaccination and Pertussis vaccination programmes which is commissioned as a National Enhanced service from selected pharmacies from May 2025. CPE Briefing 007.25 Briefing for pharmacy teams on RSV & Pertussis Vaccination Service The post Briefing 007/25: Briefing for pharmacy
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England Briefings
- 14TH MARCH 2025
- 0 COMMENTS
MHRA Drug Safety Update: Use of prolonged-release opioids in post-operative pain
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the use of prolonged-release opioids in post-operative pain. The indication for the treatment of post-operative pain has been removed from the licences of all prolonged release opioids including prolonged-release morphine and prolonged-release oxycodone, due to the increased risk of persistent post-operative opioid use
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 12TH MARCH 2025
- 0 COMMENTS
Strong support for pharmacy at Parliamentary event
Community Pharmacy England met with 50 MPs and parliamentary staff at the Houses of Parliament yesterday (Tuesday 11th March) to discuss the vital healthcare role that pharmacies play in local communities and how the critical pressures on community pharmacies are putting this at risk. During the busy Westminster event MPs were asked to support the call to protect
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 11TH MARCH 2025
- 0 COMMENTS
MHRA Class 4 Medicines Defect Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals NV)
MHRA Class 4 Medicines Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals NV) Drug alert number: EL(25)A/11 Date issued: 11 March 2025 Jubilant Pharmaceuticals NV has informed the MHRA that the Patient information leaflet (PIL) in the cartons for the batches listed in the table include an outdated PIL. These packs contain a PIL which was
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 7TH MARCH 2025
- 0 COMMENTS
Change to Creon® distribution arrangements from 1 March 2025
Viatris UK has announced that, from 1 March 2025, all orders of licensed Creon® preparations should be placed directly with Alliance Healthcare UK. This is a shift away from the current three-wholesaler (AAH, Alliance Healthcare UK and Phoenix) distribution model to using only Alliance Healthcare UK as the sole distributor of licensed Creon® preparations in
Read more
- Community Pharmacy England News
- 7TH MARCH 2025
- 0 COMMENTS
February 2025 Price Concessions 4th Update
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (28/02/2025) announced the following list of price concessions for February 2025: This is not the final update for February. We are still working with the DHSC to agree
Read more
- Community Pharmacy England News
- 7TH MARCH 2025
- 0 COMMENTS
Dispensing disallowed items
A high percentage of disallowed items are appliances or chemical reagents not listed in Part IX (the Appliances section) of the Drug Tariff or products ordered by dentists or community nurse prescribers which are not listed in their respective formularies. Recently, Community Pharmacy England has received queries from pharmacy owners concerned about the losses incurred
Read more
- Community Pharmacy England News
- 7TH MARCH 2025
- 0 COMMENTS
Medicine Supply Notification: Desmopressin 10microgram/dose nasal spray
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Desmopressin 10microgram/dose nasal spray MSN/2025/010 Tier 2 medium impact Date of issue: 3rd March 2025 Desmopressin 10microgram/dose nasal spray is out of stock with an anticipated re-supply date of early September 2025. Unlicensed supplies of desmopressin 10microgram/dose nasal spray are available,
Read more
- Community Pharmacy England News

Archives

National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials

Briefing 008/25: Briefing for general practice teams – the Community Pharmacy Respiratory Syncytial Virus (RSV) and Pertussis Vaccination Service

Briefing 007/25: Briefing for pharmacy teams – the RSV and Pertussis Vaccination Service

MHRA Drug Safety Update: Use of prolonged-release opioids in post-operative pain

Strong support for pharmacy at Parliamentary event

MHRA Class 4 Medicines Defect Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals NV)

Change to Creon® distribution arrangements from 1 March 2025

February 2025 Price Concessions 4th Update

Dispensing disallowed items

Medicine Supply Notification: Desmopressin 10microgram/dose nasal spray

Get in Touch

Working together with key healthcare stakeholders, local councils and other healthcare organisations as necessary to ensure that the provision of pharmaceutical services continues to be an integral part of Health and Social Care